FDA NDC Directory · JSON-LD · Markdown

Lacosamide

NDC 27808-243 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTris Pharma Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA208308
Dosage form / routeTABLET · ORAL
Active ingredientsLACOSAMIDE (50 mg/1)
Marketing started20220319
Package count1

External sources

Source: openFDA. Public-domain (CC0).